Engerix B
Sponsors
University of North Carolina, Chapel Hill, Immutep S.A.S., GlaxoSmithKline, Crucell Holland BV, Sheffield Teaching Hospitals NHS Foundation Trust
Conditions
Communicable DiseasesHBVHIVHIV InfectionsHealthyHepatitis BHepatitis B InfectionInfections, Papillomavirus
Phase 1
Phase 2
A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses
CompletedNCT02434848
Start: 2015-07-23End: 2022-06-10Updated: 2022-09-29
Non Inferiority Trial of Locally Manufactured 'Hepa-B' Vaccine in Bangladesh.
CompletedNCT03627507
Start: 2018-07-29End: 2019-06-03Updated: 2022-02-11
Phase 3
Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects
CompletedNCT00652938
Start: 2008-04-09End: 2010-01-08Updated: 2018-08-17
Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns
CompletedNCT01349283
Start: 2011-05-31End: 2013-11-30Updated: 2014-03-04